SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Ocugen gets provisional approval in Bahamas for OCU400

Ocugen said it received provisional approval and priority designation in The Bahamas to provide OCU400 to patients for retinitis pigmentosa.

OCGN

Related stories